Clinical and Economic Impact of Upfront Next-Generation Sequencing for Metastatic NSCLC in East Asia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical and Economic Impact of Upfront Next-Generation Sequencing for Metastatic NSCLC in East Asia

Published:2022-03 Issue:3 Volume:3 Page:100290
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Loong Herbert H.,Wong Carlos K.H.,Chan Catherine P.K.,Chang Andrea,Zhou Zheng-Yi,Tang Wenxi,Gibbs Meaghan

Funder

Boehringer Ingelheim

Bayer

Eisai

AbbVie

Eli Lilly and Company

Novartis Pharmaceuticals Corporation

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference40 articles.

1. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003;Yang;Chest,2005

2. The impact of genomic changes on treatment of lung cancer;Cardarella;Am J Respir Crit Care Med,2013

3. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs;Kris;JAMA,2014

4. Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma;Salgia;Expert Rev Mol Diagn,2016

5. First-line erlotinib therapy until and beyond response evaluation criteria in solid tumors progression in Asian patients with epidermal growth factor receptor mutation–positive non–small-cell lung cancer: the ASPIRATION study;Park;JAMA Oncol,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review;Value in Health;2024-09

2. Lung adenocarcinoma with EGFR L858R-K860I and L858R-L861F doublet mutations from which the L858R mutation is undetectable through the cobas EGFR mutation test v2;Pathology - Research and Practice;2024-05

3. RET Fusion Testing in Patients With NSCLC: The RETING Study;JTO Clinical and Research Reports;2024-04

4. Effectiveness of next-generation sequencing for patients with advanced non-small-cell lung cancer: a population-based registry study;ESMO Open;2024-01

5. Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group;ESMO Open;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3